ev3 CE marks carotid stent, US trial underway
This article was originally published in Clinica
Executive Summary
Endovascular medical device firm ev3 is pressing ahead with efforts to exploit the carotid artery stent market. It recently gained the all-clear to sell its Protege GPS nitinol self-expanding tapered stent for treating carotid artery disease in Europe, and expects to complete a major US trial of its carotid products in the third quarter of this year.